Antiretroviral-Sparing Concept With HIV-specific T Cell Precursors With High Proliferative Capacity (PHPC)

NCT00918840 · clinicaltrials.gov ↗

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV Infection

Interventions

BIOLOGICAL: DermaVir
BIOLOGICAL: Placebo
DRUG: HAART

Sponsor

Genetic Immunity

Collaborators

[object Object]
[object Object]